Sertraline is an anti-depressant and falls in the central nervous system segment of drugs. This is the first approval for a dossier developed by the group in India and submitted in France, the company informed the Bombay Stock Exchange.
The annual sales of Sertraline in 2004-05 were estimated at 70 mn Euro, it said.
The group's subsidiary, Zydus France SAS has launched a total of 74 generic presentations since its foray in the French generics market in September last year.
These include - Simvastatin in the cardiovascular segment and Omeprazole in the gastrointestinal segment, it added.